Susquehanna International Securities, Ltd. Astrazeneca PLC Call Options Transaction History

Susquehanna International Securities, Ltd.

$389 Million
Q3 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $578,463 - $665,990	10,900 Added 77.3%	25,000 $1.37 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $525,648 - $587,688	14,100 New	14,100 $582,000

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.45 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.97 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.64 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.61 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.35 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Account